130 related articles for article (PubMed ID: 17310874)
1. Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers.
Kudrimoti M; Lee EY; Kang Y; Ahmed M; Mohiuddin M
J Ky Med Assoc; 2007 Jan; 105(1):18-22. PubMed ID: 17310874
[TBL] [Abstract][Full Text] [Related]
2. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
Edden Y; Wexner SD; Berho M
Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
4. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
[TBL] [Abstract][Full Text] [Related]
5. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
[TBL] [Abstract][Full Text] [Related]
6. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
[TBL] [Abstract][Full Text] [Related]
7. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
8. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
[TBL] [Abstract][Full Text] [Related]
10. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue.
Stift A; Prager G; Selzer E; Widder J; Kandioler D; Friedl J; Teleky B; Herbst F; Wrba F; Bergmann M
Int J Oncol; 2003 Nov; 23(5):1269-75. PubMed ID: 14532965
[TBL] [Abstract][Full Text] [Related]
11. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
[TBL] [Abstract][Full Text] [Related]
12. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?
Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H
Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099
[TBL] [Abstract][Full Text] [Related]
13. Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy.
Reerink O; Karrenbeld A; Plukker JT; Verschueren RC; Szabó BG; Sluiter WJ; Hospers GA; Mulder NH
Anticancer Res; 2004; 24(2C):1217-21. PubMed ID: 15154650
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
[TBL] [Abstract][Full Text] [Related]
15. Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis.
Hur H; Tulina I; Cho MS; Min BS; Koom WS; Lim JS; Ahn JB; Kim NK
Dis Colon Rectum; 2016 Dec; 59(12):1174-1182. PubMed ID: 27824703
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.
Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD
Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598
[TBL] [Abstract][Full Text] [Related]
17. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
Heeren PA; Kloppenberg FW; Hollema H; Mulder NH; Nap RE; Plukker JT
Anticancer Res; 2004; 24(4):2579-83. PubMed ID: 15330218
[TBL] [Abstract][Full Text] [Related]
18. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage II/III rectal cancers.
Fucini C; Messerini L; Saieva C; Orzalesi L; Carroni V; Bartolini N
Colorectal Dis; 2012 Feb; 14(2):e64-71. PubMed ID: 21848899
[TBL] [Abstract][Full Text] [Related]
20. NPTX2 is associated with neoadjuvant therapy response in rectal cancer.
Karagkounis G; Thai L; DeVecchio J; Gantt GA; Duraes L; Pai RK; Kalady MF
J Surg Res; 2016 May; 202(1):112-7. PubMed ID: 27083956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]